[Ciprofloxacin in the treatment of urogenital infections in women].
The examination included 51 women. In 25.5 and 33.3 per cent of them gonorrhea and association of gonorrhea with trichomoniasis, chlamydiosis or ureaplasmosis and in 35.3 and 5.9 per cent chlamydiosis and association of chlamydiosis with trichomoniasis were stated respectively. 56.9 and 17.6 per cent of the women had the mixed infection in the urogenital tract and in extragenital foci respectively. The regimen of the chronic gonorrhea therapy included the use of ciprofloxacin in the initial dose of 500 mg and the subsequent doses of 250 mg every 12 hours, the course dose being 1.25 g. The efficacy of the treatment amounted to 100 per cent. The treatment of the patients with gonorrhea association with ureaplasmosis in a dose of 500 mg administered every 12 hours (the course dose of 5 g) resulted in eradication of ureaplasma in 71.4 per cent of the patients. The efficacy of the chlamydiosis treatment in the course dose of 10 g (500 mg every 12 hours) amounted to 88 per cent.
Bakalova
L A
LA
Akovbian
V A
VA
Bednova
V N
VN
D000293:Adolescent; D000328:Adult; D000368:Aged; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002690:Chlamydia Infections / Q000188:drug therapy; D002908:Chronic Disease; D002939:Ciprofloxacin / Q000627:therapeutic use*; D005260:Female; D052776:Female Urogenital Diseases / Q000188:drug therapy*; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D016869:Ureaplasma Infections / Q000188:drug therapy
D000890:Anti-Infective Agents; D002939:Ciprofloxacin